Literature DB >> 9835528

Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA.

T J Falla1, I Chopra.   

Abstract

The basis of joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli mediated by hipA was examined. An antibiotic tolerance phenotype was produced by overexpression of hipA under conditions that did not affect the growth rate of the organism. Overexpressing hipA probably decreases the period in which bacteria are susceptible to the antibiotics by temporarily affecting some aspect of chromosome replication or cell division.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9835528      PMCID： PMC106036     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Structure and organization of hip, an operon that affects lethality due to inhibition of peptidoglycan or DNA synthesis.

Authors:  D S Black; A J Kelly; M J Mardis; H S Moyed
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

2.  Transposition derivatives of an Hfr strain of Escherichia coli K-12.

Authors:  C M Berg; R Curtiss
Journal:  Genetics       Date:  1967-07       Impact factor: 4.562

3.  The terminus region of the Escherichia coli chromosome contains two separate loci that exhibit polar inhibition of replication.

Authors:  T M Hill; J M Henson; P L Kuempel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

Review 4.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  S Handwerger; A Tomasz
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

5.  hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis.

Authors:  H S Moyed; K P Bertrand
Journal:  J Bacteriol       Date:  1983-08       Impact factor: 3.490

6.  Molecular basis of symbiosis between Rhizobium and legumes.

Authors:  C Freiberg; R Fellay; A Bairoch; W J Broughton; A Rosenthal; X Perret
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

7.  Plasmid pSC101 harbors a recombination site, psi, which is able to resolve plasmid multimers and to substitute for the analogous chromosomal Escherichia coli site dif.

Authors:  F Cornet; I Mortier; J Patte; J M Louarn
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

8.  Escherichia coli XerC recombinase is required for chromosomal segregation at cell division.

Authors:  G Blakely; S Colloms; G May; M Burke; D Sherratt
Journal:  New Biol       Date:  1991-08

9.  Molecular cloning and expression of hipA, a gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis.

Authors:  H S Moyed; S H Broderick
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

10.  Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents.

Authors:  J S Wolfson; D C Hooper; G L McHugh; M A Bozza; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191
View more
  47 in total

Review 1.  Riddle of biofilm resistance.

Authors:  K Lewis
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

3.  Killing by ampicillin and ofloxacin induces overlapping changes in Escherichia coli transcription profile.

Authors:  Niilo Kaldalu; Rui Mei; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

4.  Regulation of phenotypic variability by a threshold-based mechanism underlies bacterial persistence.

Authors:  Eitan Rotem; Adiel Loinger; Irine Ronin; Irit Levin-Reisman; Chana Gabay; Noam Shoresh; Ofer Biham; Nathalie Q Balaban
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

5.  Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131.

Authors:  James R Johnson; Stephen B Porter; Paul Thuras; Timothy J Johnson; Lance B Price; Veronika Tchesnokova; Evgeni V Sokurenko
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

6.  Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.

Authors:  Iris Keren; Devang Shah; Amy Spoering; Niilo Kaldalu; Kim Lewis
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

7.  Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins.

Authors:  Nora Vázquez-Laslop; Hyunwoo Lee; Alexander A Neyfakh
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

8.  Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation.

Authors:  Shaleen B Korch; Thomas M Hill
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

9.  Kinase activity of overexpressed HipA is required for growth arrest and multidrug tolerance in Escherichia coli.

Authors:  Frederick F Correia; Anthony D'Onofrio; Tomas Rejtar; Lingyun Li; Barry L Karger; Kira Makarova; Eugene V Koonin; Kim Lewis
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

10.  Noncognate Mycobacterium tuberculosis toxin-antitoxins can physically and functionally interact.

Authors:  Ling Zhu; Jared D Sharp; Hiroshi Kobayashi; Nancy A Woychik; Masayori Inouye
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.